//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Online Registration is Open!
Register by Tuesday, May 3 to Avoid the $100 Onsite Fee.
»Pricing Chart

Download Brochure

Add to Outlook Calendar

Find Another IBC Event

TIDES: Oligonucleotide and Peptide Therapeutics


Agenda CSS

May 09-12, 2016
Long Beach Convention & Entertainment Center
Long Beach, CA

Alt Language

Alternative Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

2013 Event Wrap-Up

2013 Event Wrap-Up

Thank you for making TIDES 2013 a success!

Event Guide

The 15th Anniversary TIDES 2013 conference gave 800 attendees the chance to get up to speed with oligonucleotide and peptide manufacturing, oligonucleotide therapeutics discovery, peptide discovery and development and nucleic acids technologies for molecular diagnostics. In addition - numerous networking opportunities allowed attendees to meet with exhibitors, poster presenters, speakers and peers.

Read Highlight from the Diagnostic Supply Chain Discussion Panel
by Dick Keys, Advance Biotechtonics Consulting

TIDES 2013 photo TIDES 2013 photo TIDES 2013 photo

What did TIDES 2013 attendees have to say about the event?

"TIDES conferences is a must for any science professional engaged in oligos or peptide work." - Anthony Maina, Doctoral Student, Seton Hall University

"The leading forum for 'TIDES'" - Maurice Gaubatz, President, Pyxant Labs

"Excellent balance between academic science & industrial application." - Peter Timmerman, Chief Technology Officer, Pepscan Therapeutics

"Small group & informed presentation style promoted rapport and engagement of audience." - Phil Weaver, Senior Project Manager, Genzyme

"The most useful Pre-TIDES Conference I have ever attended - well-structured program with broad spectrum of presenters from CMO, sponsors, and consultants." - Neil Thompson, Business Manager, Polypeptide Laboratories A/S

"As a supplier in the oligonucleotide industry, this workshop was very helpful to understand the requirements of the oligonucleotide industry." - Siegmar Pulst, Director, Digital Specialty Chemicals

"I enjoyed the presentations from company development pipelines (Synergy, Isis, Alnylam)." - John Lucas, Principal Scientist, Irnowood Pharmaceuticals

"TIDES is THE venue for oligonucleotides and peptides together. The complete package only exists in one setting and that's TIDES. There is no forum that has the same level of expertise in one place at one time other than TIDES." - Scott Petersen, Ph.D., Chief Scientific Officer, Liposciences, Inc.